Human multiple myeloma cells express peroxisome proliferator-activated receptor γ and undergo apoptosis upon exposure to PPARγ ligands

Clinical Immunology

Volumn 113, Issue 2, 2004, Pages 203-213

  Ray, Denise M ^a   Bernstein, Steven H ^b   Phipps, Richard P ^a,b  

^a School of Medicine and Dentistry   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Apoptosis; Myeloma; PPAR ; Prostaglandins; Thiazolidinedione

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ALITRETINOIN; ANTINEOPLASTIC AGENT; BIOTIN; CIGLITAZONE; DNA NUCLEOTIDYLEXOTRANSFERASE; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; RETINOID X RECEPTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; MULTIPLE MYELOMA; MYELOMA CELL; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; BIOLOGICAL RESPONSE MODIFIERS; BLOTTING, WESTERN; CASPASES; CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTERLEUKIN-6; LIGANDS; MEMBRANE POTENTIALS; MITOCHONDRIA; MULTIPLE MYELOMA; PPAR GAMMA; PROSTAGLANDIN D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIAZOLIDINEDIONES; TRETINOIN;

EID: 4644371751     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.06.011     Document Type: Article

References (42)

1. J. Mehta S. Singhal Myeloma 2002 Taylor and Francis London 539 pp.
2. P. Sonneveld, and C.M. Segeren Changing concepts in multiple myeloma: from conventional chemotherapy to high-dose treatment Eur. J. Cancer 39 2002 9 18
3. T. Hideshima, P. Richardson, D. Chauhan, V.J. Palombella, P.J. Elliott, J. Adams, and K.C. Anderson The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells Cancer Res. 61 2001 3071 3076
4. N. Mitsiades, C.S. Mitsiades, P.G. Richardson, V. Poulaki, Y.T. Tai, D. Chauhan, G. Fanourakis, X. Gu, C. Bailey, T.A. Libermann, R. Schlossman, N.C. Munshi, T. Hideshima, and K.C. Anderson The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications Blood 101 2003 2377 2380
5. T. Hideshima, D. Chauhan, Y. Shima, N. Raje, F.E. Davies, Y.T. Tai, S.P. Treon, B. Lin, R.L. Schlossman, P. Richardson, G. Muller, D.I. Stirling, and K.C. Anderson Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy Blood 96 2000 2943 2950
6. N. Mitsiades, C.S. Mitsiades, V. Poulaki, D. Chauhan, P.G. Richardson, T. Hideshima, N.C. Munshi, S.P. Treon, and K.C. Anderson Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications Blood 99 2002 4525 4530
7. R.A. Daynes, and D.C. Jones Emerging roles of PPARs in inflammation and immunity Nat. Rev., Immunol. 2 2002 748 759
8. 2 is a ligand for the adipocyte determination factor PPARγ Cell 83 1995 803 812
9. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation Cell 83 1995 813 819
10. 2 and related compounds: an update, prostaglandins leukotrienes essent Fatty Acids 47 1992 1 12
11. S.S. Davies, A.V. Pontsler, G.K. Marathe, D.A. Harrison, R.C. Murphy, J.C. Hinshaw, G.D. Prestwich, A.S. Hilaire, S.M. Prescott, G.A. Zimmerman, and T.M. McIntyre Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists J. Biol. Chem. 276 2001 16015 16023
12. T.M. McIntyre, A.V. Pontsler, A.R. Silva, A. St. Hilaire, Y. Xu, J.C. Hinshaw, G.A. Zimmerman, K. Hama, J. Aoki, H. Arai, and G.D. Prestwich Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPAR gamma agonist Proc. Natl. Acad. Sci. U. S. A. 100 2003 131 136
13. J.M. Lehmann, L.B. Moore, T.A. Smith-Oliver, W.O. Wilkison, T.M. Willson, and S.A. Kliewer An antidiabetic Thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma J. Biol. Chem. 270 1995 12953 12956
14. Y. Wang, W.W. Porter, N. Suh, T. Honda, G.W. Gribble, L.M. Leesnitzer, K.D. Plunket, D.J. Mangelsdorf, S.G. Blanchard, T.M. Willson, and M.B. Sporn A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma Mol. Endocrinol. 14 2000 1550 1556
15. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator activated receptor-γ is a negative regulator of macrophage activation Nature 391 1998 79 82
16. C. Jiang, A.T. Ting, and B. Seed PPAR-γ ligands inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
17. 2, and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells Immunology 105 2002 23 34
18. Y. Tsubouchi, H. Sano, Y. Kawahito, S. Mukai, R. Yamada, M. Kohno, K.I. Inoue, T. Hla, and M. Kondo Inhibition of human lung cancer cell growth by the peroxisome proliferator activated receptor-γ agonists through induction of apoptosis Biochem. Biophys. Res. Commun. 270 2000 400 405
19. S. Kitamura, Y. Miyazaki, Y. Shinomura, S. Kondo, S. Kanayama, and Y. Matsuzawa Peroxisome proliferator activated receptor γ induces growth arrest and differentiation markers of human colon cancer cells Jpn. J. Cancer Res. 90 1999 75 80
20. E. Mueller, P. Sarraf, P. Tontonoz, R.M. Evans, K.J. Martin, M. Zhang, C. Fletcher, S. Singer, and B.M. Spiegelman Terminal differentiation of human breast cancer through PPARγ Mol. Cell 1 1998 465 470
21. X. Xin, S. Yang, J. Kowalski, and M.E. Gerritsen Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo J. Biol. Chem. 274 1999 9116 9121
22. E. Mueller, M. Smith, P. Sarraf, T. Kroll, A. Aiyer, D.S. Kaufman, W. Oh, G. Demetri, W.D. Figg, X.P. Zhou, C. Eng, B.M. Spiegelman, and P.W. Kantoff Effects of ligand activation of peroxisome proliferator activated receptor γ in human prostate cancer Proc. Natl. Acad. Sci. U. S. A. 97 2000 10990 10995
23. G.D. Demetri, C.D. Fletcher, E. Mueller, P. Sarraf, R. Naujoks, N. Campbell, B.M. Spiegelman, and S. Singer Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma Proc. Natl. Acad. Sci. U. S. A. 96 1999 3951 3956
24. 2 induce apoptosis in normal and malignant B-lineage cells J. Immunol. 165 2000 6941 6948
25. J. Padilla, E. Leung, and R.P. Phipps Human B lymphocytes and B lymphomas express PPAR-γ and are killed by PPAR-γ agonists Clin. Immunol. 103 2002 22 33
26. D.F. Jelinek, G.J. Ahmann, P.R. Greipp, S.M. Jalal, J.J. Westendorf, J.A. Katzmann, R.A. Kyle, and J.A. Lust Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications Cancer Res. 53 1993 5320 5327
27. Y. Matsuoka, G.E. Moore, Y. Yagi, and D. Pressman Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma Proc. Soc. Exp. Biol. Med. 125 1967 1246 1250
28. S. Raha, and B.H. Robinson Mitochondria, oxygen free radicals, and apoptosis Semin. Med. Genet. 106 2001 62 70
29. G.M. Cohen Caspases: the executioners of apoptosis Biochem. J. 326 1997 1 16
30. C.M. Troy, and M.L. Shelanski Caspase-2 redux Cell Death Differ. 10 2003 101 107
31. B. Joseph, O. Lefebvre, C. Mereau-Richard, P.M. Danze, M.T. Belin-Plancot, and P. Formstecher Evidence for the involvement of both retinoic acid receptor- and retinoic X receptor-dependent signaling pathways in the induction of tissue transglutaminase and apoptosis in the human myeloma cell line RPMI 8226 Blood 91 1998 2423 2432
32. W.S. Dalton, and R. Jove Drug resistance in multiple myeloma: approaches to circumvention Semin. Oncol. 26 1999 23 27
33. L. Michalik, B. Desvergne, and W. Wahli Peroxisome-proliferator-activated receptors and cancers: complex stories Nat. Rev. 4 2004 61 70
34. P. Sarraf, E. Mueller, D. Jones, F.J. King, D.J. DeAngelo, J.B. Partridge, S.A. Holden, L.B. Chen, S. Singer, C. Fletcher, and B.M. Spiegelman Differentiation and reversal of malignant changes in colon cancer through PPARγ Nat. Med. 4 1998 1046 1052
35. G.L. Rubin, Y. Zhao, A.M. Kalus, and E.R. Simpson Peroxisome proliferator-activated receptor γ ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy Cancer Res. 60 2000 1604 1608
36. S.W. Chung, B.Y. Kang, S.H. Kim, Y.K. Pak, D. Cho, G. Trinchieri, and T.S. Kim Oxidized low density lipoprotein inhibits Interleukin-12 production in lipopolysaccharide-activated macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-κB J. Biol. Chem. 275 2000 32681 32687
37. D. Kelly, J.I. Campbell, T.P. King, G. Grant, E.A. Jansson, A.G.P. Coutts, S. Pettersson, and S. Conway Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and Rel A Nat. Immunol. 5 2004 104 112
38. 2 terminus potentiates naphthoquinone analog-induced apoptosis J. Biol. Chem. 276 2001 24638 24644
39. D. Gupta, S.P. Treon, T. Hideshima, K. Podar, Y.T. Tai, B. Lin, S. Lentzsch, F.E. Davies, D. Chauhan, R.L. Schlossman, P. Richardson, P. Ralph, L. Wu, F. Payvandi, G. Muller, D.I. Stirling, and K.C. Anderson Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications Leukemia 15 2001 1950 1961
40. S.S. Palakurthi, H. Aktas, L.M. Grubissich, R.M. Mortensen, and J.A. Halperin Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor γ and mediated by inhibition of translation initiation Can. Res. 61 2001 6213 6218
41. 2: the endogenous electrophile that induces neuronal apoptosis Proc. Natl. Acad. Sci. U. S. A. 99 2002 7367 7372
42. K. Setoguchi, Y. Misaki, Y. Terauchi, T. Yamauchi, K. Kawahata, T. Kadowaki, and K. Yamamoto Peroxisome proliferator-activated receptor-γ haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis J. Clin. Invest. 108 2001 1667 1675